SFX by Ex Libris Inc.

Title:	Synthesis and Evaluation of 6,11-Ethanohexahydrobenzo[b]quinolizidines: A New Class of Noncompetitive N-Methyl-D-aspartate Antagonists
Source:	Journal of Medicinal Chemistry [0022-2623] Subramanyam, Chakrapani yr:1995

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ortar, G. "Tetrahydrolipstatin Analogues as Modulators of Endocannabinoid 2-Arachidonoylglycerol Metabolism." Journal of medicinal chemistry 51.21 (2008): 6970-6979.
description	2.	Terzioglu, N. "Snythesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H-4 receptor antagonists." Bioorganic & medicinal chemistry letters 14.21 (2004): 5251-5256.
description	3.	Stanley, S F F. "Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior." Proceedings of the National Academy of Sciences of the United States of America 82.11: 3940-3.
description	4.	Kondru, R. "Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists." Molecular pharmacology 73.3 (2008): 789-800.
description	5.	Nelson, Derek W. "Structure-Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists." Journal of medicinal chemistry 49.12 (2006): 3659-88.
description	6.	Bisogno, T. "A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects." British Journal of Pharmacology 169.4 (2012): 784-793.
description	7.	Zhang, P. "Structure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5." Bioorganic & medicinal chemistry 18.9 (2010): 3026-35.
description	8.	BARBER, C. "1-Amido-1-phenyl-3-piperidinylbutanes-CCR5 antagonists for the treatment of HIV: Part 2." Bioorganic & medicinal chemistry letters 19.5 (2009): 1499-1503.
description	9.	Baumgarten, Henry E. "Dechlorination of some chloronitropicolines." Journal of the American Chemical Society 76 (1954): 596-.
description	10.	LUKYANOV, Sergey M. "Microwave-assisted synthesis and transformations of sterically hindered 3-(5-tetrazolyl)pyridines." Tetrahedron 62.8 (2006): 1849-1863.
description	11.	McLean, Thomas H. "1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2A Receptor Agonists." Journal of medicinal chemistry 49.19 (2006): 5794-5803.
description	12.	Schaeffer, M. "Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons." Proceedings of the National Academy of Sciences of the United States of America 110.4 (2013): 1512-1517.
description	13.	Bomar, Martha G. "Modulation of the cannabinoid receptors by hemopressin peptides." Life sciences 92.8-9 (2012): 520-524.
description	14.	Hu, Sherry S. "Architecture of cannabinoid signaling in mouse retina." Journal of comparative neurology 518.18 (2010): 3848-3866.
description	15.	Hancock, A. "In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H-3 receptor antagonists." Basic & clinical pharmacology & toxicology 95.3 (2004): 144-152.
description	16.	Bisogno, T. "Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2-Arachidonoylglycerol." ChemMedChem 4.6 (2009): 946-950.
description	17.	Elders, N. "A resource-efficient and highly flexible procedure for a three-component synthesis of 2-imidazolines." Journal of organic chemistry 72.16 (2007): 6135-6142.
description	18.	Williams, Steven C R C. "PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans." Nature 450.7166 (2007): 106-9.
description	19.	Erondu, N. "Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults." Cell metabolism 4.4 (2006): 275-82.
description	20.	Kuo, Lydia E. E. "Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome." Nature medicine 13.7 (2007): 803-811.